Icon vs its peers
The 5 largest Services-Commercial Physical & Biological Research companies by market value, prices of Nov 20, 2026
Icon is the largest of the 5 biggest Services-Commercial Physical & Biological Research companies on OQRO by market value, at $14.3B. Its revenue of $8.25B in fiscal 2025 is the largest of the group. It keeps 5% of revenue as operating profit, 2nd of 5 (median −157%). Revenue grew 1% on the year before, against a median of −14.5%.
Side by side
| Company | Market value | Revenue | Growth y/y | 5-yr growth / yr | Gross margin | Operating margin | Net margin | Free cash flow margin | R&D / revenue | Price / earnings | Price / sales | FCF yield | Stock, 12 months |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IconICLR · FY2025 | $14.3B | $8.25B | +0.8% | +24.2% | 26.4% | 5.4% | 2.8% | 10.4% | — | 62.3x | 1.7x | 6.0% | +18.1% |
| AbsciABSI · FY2025 | $1.3B | $2.8M | −38.2% | −10.1% | — | −4297% | −4114% | −3358% | 2908% | — | 463x |
Each company’s latest fiscal year (FY), so the years can end a few months apart. Price ratios divide today’s market value by that year’s figure; price / earnings is left out on a loss. “—” means the company did not tag that line in its annual report.
Operating margin
- NRC16%
- ICLR5%
- MXCT−157%
- OABI−369%
- ABSI−4297%
Revenue growth, latest year
- ICLR+0.8%
- NRC−4.0%
- MXCT−14.5%
Compare Icon head to head
Where Icon’s revenue comes from and where it goes: Icon revenue breakdown. Twenty years of results: Icon financial history.
Common questions
Who are Icon's competitors?
The largest companies in its industry (Services-Commercial Physical & Biological Research) by market value: Absci (ABSI), Omniab (OABI), Nrc Health (NRC) and Maxcyte (MXCT). They share Icon's industry listing; not every one competes with it on every product.
Is Icon bigger than Absci?
Yes, by market value: Icon is worth $14.3B and Absci $1.3B. By revenue, Icon brought in $8.25B in fiscal 2025 and Absci $2.8M in fiscal 2025.
How does Icon's valuation compare with its peers?
Icon trades at 1.7x its annual revenue and 62.3x its net income. The median of the other 4 companies is 20.3x revenue. A higher ratio means investors pay more for each dollar the company makes today, usually because they expect it to grow faster.
Where these figures come from
The group is the companies OQRO lists in the same industry as Icon (Services-Commercial Physical & Biological Research), the largest 4 by market value, plus Icon. Companies whose latest annual report is more than a year and a half old, or that report in a currency other than the dollar, are left out.
Revenue, operating income, net income, gross profit, research and development and free cash flow (cash from operations minus capital expenditure) are each company’s own full-year lines from its latest 10-K, as tagged in XBRL (SEC companyfacts). Market value is the last close times the shares outstanding on the latest filing. Price / earnings is market value over net income; price / sales is market value over revenue; free cash flow yield is free cash flow over market value. Five-year growth is the yearly rate that takes revenue from five fiscal years before to the latest. This page describes the past and is not investment advice. No language model wrote it.


